New drug helps schizophrenic cognition


	New drug helps schizophrenic cognition

Fast T friend

9-24-2009 6:56 AM

106 views

tags:

biolinerx, health, medical, mental, research

Fast T friend says:

The global market for anti-psychotic drugs is expected to reach $17 billion in 2016, according to an assessment carried out by the Frankel Group for BiolineRX.

Add a Comment

Login to Comment. Not a member yet? Sign up

Today's Top Clips

visit the Top Clips page

View the Top Clips from September 24, 2009

Embed This Clip In Your Site...

<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/d29cd7c5-5771-4b33-8d69-3ff65dd5af47/6BCAB3D1-9494-4F57-AA50-DAEA5A6DE338/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.reuters.com/article/rbssHealthcareNews/idUSLN59542320090923" href="http://www.reuters.com/article/rbssHealthcareNews/idUSLN59542320090923" style="font-size: 11px;">www.reuters.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.reuters.com/article/rbssHealthcareNews/idUSLN59542320090923"><P> TEL AVIV, Sept 23 (Reuters) - Israeli drug development
company BiolineRX (<SPAN id="symbol_BLRX.TA_0"><A href="http://www.reuters.com/finance/stocks/overview?symbol=BLRX.TA">BLRX.TA</A></SPAN>) said on Wednesday results of a Phase
2b trial of its schizophrenia treatment BL-1020 demonstrate a
positive impact on the cognitive function of patients.<SPAN id="midArticle_byline"></SPAN></P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.reuters.com/article/rbssHealthcareNews/idUSLN59542320090923"><P> The company said it believed this was a breakthrough in the
area of treatment for schizophrenics, who suffer from a
significant decline in cognitive function, making it difficult
for them to work and perform daily tasks.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.reuters.com/article/rbssHealthcareNews/idUSLN59542320090923"><P> BiolineRX said that to the best of its knowledge, current
drugs on the market or in advanced development do not offer a
solution to this impairment.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.reuters.com/article/rbssHealthcareNews/idUSLN59542320090923"><P> Clinical trials have already shown that BL-1020 is efficient
and safe for the treatment of schizophrenics, the company added.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.reuters.com/article/rbssHealthcareNews/idUSLN59542320090923"><P> Cognition is measured by a variety of factors such as
memory, verbal abilities and the ability to learn and carry out
tasks, the company said.</P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/6BCAB3D1-9494-4F57-AA50-DAEA5A6DE338/blog/" title="blog or email this clip"><img src="http://content7.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks: Amplify.com - Don't just share the news...Amplify it!

Clipmarks: Home; New Clips; Top Clips; Dashboard

Popular Topics: News; Life; Science; Technology; Entertainment

Get Started: Sign Up; Install Clipping Tool; How Clipping Works; Clip-to-Blog™; ClipSearch

Tools and Resources: FAQ; ClipWeek; Top Clippers; Top Tags; Site Map

About Clipmarks: About Us; Contact; Copyright; Privacy; EULA

Search Options

Today's Top Clips